LIGAND PHARMACEUTICALS INC (LGND) earnings date, results and what the price requires

    Nasdaq · SEC CIK 0000886163 · SEC filings checked Oct 16, 2026

    Next report
    Nov 5, 2026
    Estimated from reporting history (91-day cycle, SEC 8-K item 2.02 results filings). Not confirmed.
    Last close
    $295.54
    Polygon.io daily close, Oct 16, 2026. End of day, not live.
    Trailing diluted EPS
    $9.65
    Sum of quarters ending Jun 30, 2026, Mar 31, 2026, Dec 31, 2025, Sep 30, 2025 · P/E 30.6

    Previous results (SEC filings)

    Quarter endedReportedRevenueNet incomeDiluted EPSSource
    Jun 30, 2026Aug 6, 2026$63.7M$48.5M$2.22Filing
    Mar 31, 2026May 7, 2026$51.7M$-13.3M$-0.67Filing
    Dec 31, 2025Feb 26, 2026$59.7M$44.8M$2.42Filing
    Sep 30, 2025Nov 6, 2025$115.5M$117.3M$5.68Filing
    Jun 30, 2025Aug 7, 2025$47.6M$4.8M$0.24Filing
    Mar 31, 2025May 8, 2025$45.3M$-42.5M$-2.21Filing
    Dec 31, 2024Feb 27, 2025$42.8M$-31.1M$-1.70Filing
    Sep 30, 2024Nov 7, 2024$51.8M$-7.2M$-0.39Filing

    What would LIGAND PHARMACEUTICALS INC have to report for its valuation to change?

    At $295.54, with a 9.0% required return and a 18× earnings multiple in 5 years, earnings per share must grow about 21.2% a year, to $25.26. On that path the next quarter needs diluted EPS near $6.89, against $5.68 in the quarter ended Sep 30, 2025.

    Are you considering buying, or do you already own shares?

    Compare buying at the last close now with waiting for results: if the report moves the growth the price requires, the entry price you would accept changes with it.

    ResultOriginalYours
    Required EPS growth / year21.2%21.2%
    EPS needed in final year$25.26$25.26

    Changed: nothing yet. Model: EPS × (1+g)^years × final P/E, discounted at the required return, equals today's price. Inputs: SEC diluted EPS and the dated close above.

    Prepare for earnings across my investments — $399/month

    Keep working models for the companies you follow, compare your expectations with reported results, and review what changes your investment decision. LGND goes in with your buy-or-wait comparison and assumptions preserved.

    Start Desk — $399/month

    Figures come from SEC EDGAR XBRL filings. Dates marked "estimated" are calculated from the company's past results filings and are not confirmed. Not investment advice.